ZNF300 promotes proliferation and migration of hepatocellular carcinoma by upregulating c-MYC gene expression

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. Currently, the treatments of HCC are limited to surgical resection and liver transplantation, and there is no effective systemic therapy.